JONATHAN SPORN, MD

Plain English
This study looked at a rare type of lymph node metastasis in lung cancer, specifically in patients with non-small cell lung cancer (NSCLC). Researchers found that 6% to 11% of NSCLC patients have metastases in abdominal lymph nodes, with paracholedochal lymph node involvement being very uncommon. Understanding how these metastases occur and improving detection methods, like using PET/CT scans, is important because they can significantly influence treatment options and outcomes for patients. Who this helps: This helps patients with lung cancer and the doctors treating them.

Plain English
This study looked at a rare but serious complication that can happen during CPR, called liver rupture, particularly when using a device called the CORPULS system. They found that such injuries can lead to dangerous bleeding, highlighting the need for better follow-up care after CPR; in one case, a patient with liver damage was successfully treated thanks to a team of medical professionals. This matters because understanding these risks can improve how doctors respond to patients after resuscitation. Who this helps: This helps patients who undergo CPR and their medical teams.

Plain English
Researchers studied a new drug called GM-2505, designed to treat major depressive disorder (MDD), by testing its safety and effects on 48 healthy volunteers. They found that doses of up to 20 mg were generally safe, causing only mild side effects like temporary increases in blood pressure. The drug showed meaningful changes in brain activity and hormone levels similar to existing psychedelic treatments, indicating it might be effective for depression treatment and has a shorter duration of effects compared to psilocybin, making it potentially easier to use in clinical settings. Who this helps: This helps patients with major depressive disorder seeking new treatment options.

Plain English
This study focused on a new treatment called GM-1020, designed to help people with depression. Researchers found that GM-1020 works effectively like ketamine at providing quick relief from depressive symptoms without causing significant side effects when taken orally. They showed that it can be given at doses that are safe while maintaining its effectiveness in tests conducted on rodents. Who this helps: This research benefits patients struggling with depression who need faster-acting treatments.

Plain English
This study looked at whether R-(-)-ketamine could stop rats from becoming tolerant to the effects of alcohol, which means they would need more alcohol to feel the same effects over time. The researchers found that tolerance developed only in grip strength after drinking alcohol, but when given R-(-)-ketamine before alcohol, there was a strong indication it could help prevent tolerance from forming (with a p-value of 0.062). This matters because finding ways to prevent tolerance could improve how we treat alcohol use disorders. Who this helps: This helps patients struggling with alcohol use disorder.

Plain English
This study looked at how a variant of ketamine, called R-(-)-ketamine, affects addiction to opioids like morphine. The researchers found that R-(-)-ketamine helped reduce withdrawal symptoms and also stopped mice from preferring morphine without creating a preference for itself. This is important because it shows that R-(-)-ketamine might be a safer and more effective option for treating opioid addiction without causing negative side effects like feeling down or disconnected. Who this helps: This helps patients struggling with opioid addiction and healthcare providers looking for better treatment options.

Plain English
This study looked at African-American cancer patients with sickle cell trait and other blood disorders to see how these conditions affect their health during cancer treatment. The researchers found that these patients were 19% more likely to experience serious health complications, like hospitalizations, compared to African-American patients without these traits and 23% more likely than non-Hispanic white patients. This is important because it highlights a new reason why African-American patients might have worse cancer outcomes. Who this helps: Patients with sickle cell trait and other blood disorders.

Plain English
This study looked at how specific proteins called macroH2A histones affect the structure of DNA in cells, especially during events like DNA damage. The researchers discovered that different types of macroH2A proteins interact with DNA in different ways, with macroH2A2 lacking the ability to bind certain molecules that play a role in repairing DNA. They found that macroH2A proteins help keep DNA stable and organized, which is important in preventing tumors and allowing cells to maintain their functions properly. Who this helps: This benefits cancer patients and researchers working on cancer treatments.

Plain English
This research studied the effectiveness of pregabalin, at doses of 150 or 300 mg per day, in reducing pain after surgery, specifically following hernia repair, knee replacement, and hysterectomy. Across the three trials involving a total of 1,233 patients, pregabalin did not significantly reduce the pain compared to a placebo. For example, the difference in worst pain ratings was only -0.7 after hernia repair, which was not statistically significant. Who this helps: This information is useful for doctors and patients considering pain management options after surgery.

Plain English
This study looked at how the medication desvenlafaxine, used for treating major depressive disorder (MDD), affects blood pressure in patients. It found that taking desvenlafaxine at doses of 10 mg/day or higher led to significant increases in both systolic and diastolic blood pressure compared to a placebo. Specifically, 1.9% to 4.8% of patients taking higher doses experienced new hypertension, compared to only 0.8% in the placebo group. This matters because it highlights the need for doctors to monitor blood pressure in patients starting treatment with desvenlafaxine to avoid potential health risks. Who this helps: Patients being treated for major depressive disorder.

Plain English
This study examined how accurately MRI can predict the size of breast tumors compared to the actual size measured after surgery in 124 patients. The results showed that MRI agreed with the actual tumor size within 0.5 cm in about 56% of cases, but it overestimated the size in nearly 32% and underestimated it in about 12% of cases. Understanding how well MRI works for measuring tumor size is important for planning surgery and treatment. Who this helps: This helps doctors in making more informed decisions about breast cancer surgery.

Plain English
This study looked at whether pregabalin, a medication, is effective in reducing nerve pain in people with HIV. The researchers involved 377 patients, comparing those taking pregabalin to those taking a placebo for about 17 weeks. They found no significant difference in pain relief between the two groups, with a pain score change of -2.04 for pregabalin compared to -2.11 for placebo, which shows it didn’t work better than the placebo. Who this helps: This helps patients with HIV-related nerve pain by providing clarity on treatment options.

Plain English
This study looked at how well pregabalin, a medication, works for treating nerve pain caused by spinal cord injuries. A total of 220 patients participated, with 108 receiving pregabalin and 112 getting a placebo for 17 weeks. The results showed that those taking pregabalin experienced a significant reduction in their pain, with improvements starting as early as week one and continuing throughout the treatment period. Who this helps: This benefits patients suffering from nerve pain after spinal cord injuries.

Plain English
This study looked at whether sertraline, a medication, is effective and safe for treating children and teenagers aged 6 to 17 with post-traumatic stress disorder (PTSD). In the trial, 131 patients were given either sertraline or a placebo for 10 weeks, but the results showed no significant difference in PTSD symptoms between the two groups. While sertraline was generally safe, with some side effects leading to patients stopping the treatment, it did not improve PTSD symptoms compared to the placebo. Who this helps: This information is useful for parents and healthcare providers considering treatment options for young patients with PTSD.

Plain English
This study looked at a specific type of colon cancer called microsatellite stable (MSS) cancer to see how a protein involved in cell signaling, called ACVR2, is affected. Out of 51 MSS tumors analyzed, 14% had lost ACVR2, which is linked to larger tumors and specific genetic changes, indicating that this loss is important for cancer growth. Understanding how ACVR2 is inactivated in these cancers can help develop targeted treatments for patients. Who this helps: This research benefits patients with microsatellite stable colon cancer by guiding potential new treatment strategies.

Plain English
This study looked at how effective and safe the drug riluzole is for people with severe depression who haven't had success with other treatments. Nineteen patients took riluzole for six weeks, and many showed significant improvement in their depression scores after three weeks, with an average daily dose of 169 mg. This matters because it offers a potential new option for patients suffering from treatment-resistant depression, showing promise where other treatments have failed. Who this helps: Patients with treatment-resistant major depression.

Plain English
This study looked at how certain brain functions related to mood disorders, particularly severe depression, can be improved to create better treatments. Researchers found that traditional medications often don't help many patients, so they explored newer approaches that focus on enhancing brain plasticity and resilience. For example, treatments using specific compounds like NMDA antagonists and AMPA potentiators could provide better support for neural connections, potentially improving mood and emotional stability. Who this helps: This benefits patients suffering from severe and hard-to-treat depression.

Plain English
This research looks at new ways to treat depression, which has mostly relied on improving levels of certain brain chemicals called monoamines. It found that upcoming treatments might use a mix of specific drugs to target these chemicals more effectively and explore new approaches involving peptide receptor antagonists that can fine-tune brain signaling without overwhelming it. This is important because better treatments could lead to more effective help for people suffering from depression. Who this helps: This helps patients with depression seeking better treatment options.

Plain English
This study looked at how well the medication pramipexole worked alongside other treatments for patients with bipolar and unipolar depression who did not respond to typical therapies. Out of the patients who were treated, 50% with bipolar depression and 40% with unipolar depression showed moderate to significant improvement after an average of about 24 weeks on the medication. This is important because it suggests that pramipexole could be a helpful option for people struggling with these types of depression when other treatments aren’t effective. Who this helps: This helps patients with bipolar and unipolar depression who have not found relief with standard treatments.

Plain English
This research studied the use of lamotrigine, an anticonvulsant medication, in patients with bipolar disorder who did not respond to other treatments. Out of 16 patients, 8 showed significant improvement in their symptoms after taking lamotrigine, with an average increase of 16 points in a measure of daily functioning. This finding matters because it suggests that lamotrigine could be an effective option for people struggling with this challenging condition. Who this helps: Patients with treatment-resistant bipolar disorder.

Plain English
This study looked at how well a combination of two chemotherapy drugs, etoposide and cisplatin, works when given continuously for 72 hours to women with metastatic breast cancer. Out of 26 women tested, 31% saw some cancer reduction, and the average survival time was 7 months. The treatment caused some serious side effects, but it shows promise, especially for patients who haven’t had chemotherapy before. Who this helps: This helps women with metastatic breast cancer and their doctors.

Plain English
This study focused on using flow cytometry, a laboratory technique, to help diagnose lymphoma by analyzing cells from lymph nodes. Researchers reviewed 25 biopsy samples thought to have lymphoma over two years and found that flow cytometry could be useful for 16 of them; 9 out of those 16 results likely indicated lymphoma. This method is especially effective for detecting non-Hodgkin's lymphoma but may miss some cases, like Hodgkin's disease, and can produce normal results for about 15% of lymphoma cases. Who this helps: This benefits doctors and patients suspected of having lymphoma, aiding in quicker and more accurate diagnoses.

Plain English
This study focused on adult T-cell leukemia/lymphoma (ATLL), a severe blood cancer often linked with skin problems and high calcium levels due to an infection by the HTLV-I virus. The researchers described a patient with a severe case of ATLL and reviewed how this disease typically progresses. ATLL is known for being hard to treat and can rapidly worsen, making early recognition and management crucial. Who this helps: This information helps doctors and patients by improving understanding of a challenging illness.

Plain English
This study looked at how platinum levels in certain blood cells change in patients undergoing cisplatin chemotherapy, which is used to treat various cancers. Researchers tested six patients and found that platinum levels were about 2.5 ng in the blood cells shortly after treatment and decreased slowly over time, taking more than two weeks to drop significantly. This matters because measuring platinum in these blood cells may help doctors understand how the body processes the drug, potentially improving treatment strategies. Who this helps: Patients undergoing cisplatin chemotherapy.

Plain English
This study investigated how a substance called Citral affects fertility in female rats. The researchers found that after treating the rats with Citral for 60 to 100 days, the number of healthy eggs dropped significantly, leading to fewer successful pregnancies and no surviving young after extended treatment. This is important because it shows that Citral can harm female reproductive health by damaging eggs, which could have implications for fertility in humans if similar effects occur. Who this helps: This helps patients and healthcare providers concerned about reproductive health.

Plain English
This study looked at how diabetes affects the way the placenta processes glycogen in rats. Researchers found that diabetic rats had a significant buildup of glycogen and lower activity of the enzyme that helps make glycogen, while another enzyme that breaks it down was working three times harder. These changes were linked to lower insulin levels in the placenta, suggesting that the placenta tries to protect the fetus in high-sugar environments. Who this helps: This research benefits scientists and medical professionals studying diabetes in pregnancy.